FDA.reportPublic FDA data

NDC 63629-7306-01 - Gabapentin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63629-7306
Requested NDC
63629-7306-01
Package NDCs from labels
63629-7306-8, 63629-7306-1, 63629-7306-2, 63629-7306-3, 63629-7306-4, 63629-7306-5, 63629-7306-6, 63629-7306-7, 63629-7306-01
Manufacturer
Bryant Ranch Prepack
Effective date
2024-10-29
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Gabapentin - Bryant Ranch PrepackBryant Ranch Prepack2024-10-29HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
63629-7306-12020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-22020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-32020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-42020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-52020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-62020-02-25These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-12020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-22020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-32020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-42020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-52020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
63629-7306-62020-01-31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-7306-1Gabapentin90 in 1 BOTTLECAPSULE9018
63629-7306-2Gabapentin28 in 1 BOTTLECAPSULE2818
63629-7306-3Gabapentin58 in 1 BOTTLECAPSULE5818
63629-7306-4Gabapentin30 in 1 BOTTLECAPSULE3018
63629-7306-5Gabapentin60 in 1 BOTTLECAPSULE6018
63629-7306-6Gabapentin120 in 1 BOTTLECAPSULE12018
63629-7306-7Gabapentin180 in 1 BOTTLECAPSULE18018
63629-7306-8Gabapentin40 in 1 BOTTLECAPSULE4018

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-7306GABAPENTIN CAPSULE [BRYANT RANCH PREPACK]18Current NDC, Legacy NDC, 8 package rows20241109_506bf880-9564-404c-951a-703797ffdad8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-7306-1EA - Each63629-7306f5bd29ca-243c-4597-b659-f6a28ed6b6f912017-11-06
63629-7306-2EA - Each63629-73061561a545-c1aa-4a7d-be56-94e7255d28e512017-11-06
63629-7306-3EA - Each63629-7306d88b61f7-4ece-4701-a937-3997152df80412017-11-06
63629-7306-4EA - Each63629-730618d5dc4e-5eab-4e9d-ae96-f5810f1b359e12017-11-06
63629-7306-5EA - Each63629-73068512f5cd-ed39-4c18-8d93-71c674eed2de12017-11-06
63629-7306-6EA - Each63629-73062d7814ee-6885-40e6-a97f-989726e37f7112018-12-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 20 · 394 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GabapentinGABAPENTINStrides Pharma Science Limited798575b9-ddfa-4915-9574-626abbaf025f2026-04-04Warnings, Adverse reactionsExact identifier
rxcui: 310430
rxcui: 310432
rxcui: 310431
unii: 6CW7F3G59X
GabapentinGABAPENTINBryant Ranch Prepack75caca13-1432-4c0d-8d45-f029b0b2d4172026-03-31Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINBryant Ranch Prepack56378630-e7a7-4981-8212-8ea703a433d82026-03-31Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GABAPENTINGABAPENTINST. MARY'S MEDICAL PARK PHARMACY4ddc1342-5c83-f562-e063-6294a90a29ba2026-03-25Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINAdvanced Rx of Tennessee, LLCafc83432-8fce-6d2a-e053-2a95a90ae73f2026-03-19Warnings, Adverse reactionsExact identifier
rxcui: 310431
unii: 6CW7F3G59X
GabapentinGABAPENTINPD-Rx Pharmaceuticals, Inc.81774da8-cb1d-4c7d-8550-35396850d5ff2026-03-18Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINBryant Ranch Prepack912d8697-b466-48dc-88d3-d2ba90e766442026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 310430
unii: 6CW7F3G59X
GabapentinGABAPENTINRadha Pharmaceuticals, Inc.1045db4e-4c76-4a0d-bf12-019bd96a8f592026-03-11Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINDirect_Rx0b286fd1-8179-d87a-e063-6294a90a2f232026-03-05Warnings, Adverse reactionsExact identifier
rxcui: 310432
unii: 6CW7F3G59X
GabapentinGABAPENTINAmerican Health Packaginge00f5048-1a06-44f4-b244-aa2755f4be222026-03-02Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINSolco Healthcare US, LLC360d953b-4313-45ae-b933-296547d4577d2026-02-28Warnings, Adverse reactionsExact identifier
rxcui: 310430
rxcui: 310432
rxcui: 310431
unii: 6CW7F3G59X
GabapentinGABAPENTINA-S Medication Solutions54c09aa5-6724-480a-a115-c88484e39e932026-02-24Warnings, Adverse reactionsExact identifier
rxcui: 310431
unii: 6CW7F3G59X
GabapentinGABAPENTINAdvagen Pharma Ltd401b30fc-e143-4906-aae1-e5b5c190d4a82026-02-24Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINAdvagen Pharma Ltdbfee67dc-d2b1-4a00-92d9-a42be3189c742026-02-24Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINScieGen Pharmaceuticals, Inc.5ab9c18b-9568-4dcb-90b0-252aef8f8dc22026-02-20Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GABAPENTINGABAPENTINPD-Rx Pharmaceuticals, Inc.9814b76c-87c6-4746-b712-3269352a901b2026-02-16Warnings, Adverse reactionsExact identifier
rxcui: 310430
unii: 6CW7F3G59X
GABAPENTINGABAPENTINHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.d8daa30f-1cb3-46aa-9b68-d9aa5b0a21052026-02-12Warnings, Adverse reactionsExact identifier
rxcui: 310430
rxcui: 310432
rxcui: 310431
unii: 6CW7F3G59X
GabapentinGABAPENTINA-S Medication Solutionsc979f80b-d4b1-40f7-b878-b216db5f325d2026-02-10Warnings, Adverse reactionsExact identifier
rxcui: 310430
unii: 6CW7F3G59X
GabapentinGABAPENTINA-S Medication Solutionsb88b0cbc-c883-4d17-8f46-0e5bddc578352026-02-10Warnings, Adverse reactionsExact identifier
unii: 6CW7F3G59X
GabapentinGABAPENTINA-S Medication Solutions3dbd447f-4791-4c62-86b4-6f79288627852026-02-10Warnings, Adverse reactionsExact identifier
rxcui: 310431
unii: 6CW7F3G59X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.